Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6487882 | Current Opinion in Biotechnology | 2014 | 7 Pages |
Abstract
- Glycosylation is a major concern in pharmaceutical production.
- Computational models facilitate the in-silico design of glycosylation.
- Parameter calibration is required before models can be used for in-silico design.
- Glycosylation models can be linked to metabolic models to simulate fed-batch growth.
- Parameter-free and constraints-based approaches are promising future options.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Philipp N Spahn, Nathan E Lewis,